December 7th, 2005, by David Pascoe | macrolides
A topical azithromycin preparation for the treatment of acne vulgaris and rosacea. Journal of Dermatological Treatment, Volume 15, Number 5 / September 2004, Pages 295 – 302McHugh RC, Rice A, Sangha ND, et al. BACKGROUND: Erythromycin is a common therapy for acne and rosacea. A newer macrolide, azithromycin, offers superior tissue distribution and cellular concentration and is an …
November 28th, 2005, by David Pascoe | macrolides
The Effects of Macrolides on Inflammatory CellsChest, 2004;125:41S-51S.Jun Tamaoki, MD, FCCP First Department of Medicine, Tokyo Women’s Medical University School of Medicine Tokyo, Japan. Abstract: Bronchial epithelial damage and mucus hypersecretion are characteristic features of chronic airway inflammation that can impair mucociliary clearance and can cause recurrent or persistent respiratory infection. In response to chemoattractants produced by damaged or inflamed tissue, neutrophils move through …
November 23rd, 2005, by David Pascoe | macrolides
Pharmacology and therapeutics: Therapeutic potential of azithromycin in rosacea, International Journal of Dermatology, Volume 43 Issue 2, Page 151, February 2004, Ozgur Bakar, MD, Zeynep Demircay, MD, and Oya Gurbuz, MD
Abstract: Background Systemic antibiotics currently used in the treatment of rosacea are sometimes associated with uncomfortable side-effects. Therefore, a need for an effective agent with few side-effects and good patient compliance exists. Azithromycin, a …
November 22nd, 2005, by David Pascoe | macrolides
The author of this paper has been kind enough to provide a scan of the 2 page article. As well as being published in Archives of Dermatology, this paper was also presented as a poster at the 59th Annual Meeting of the American Academy of Dermatology, March 2-7, 2001. The author has also submitted a followup article that is currently being reviewed.
Oral use of azithromycin …
|
|
|
|
|
|
|
|
 |